COMMUNIQUÉS West-GlobeNewswire

Resonant Inc. to Present at The MicroCap Conference in New York on October 1st
17/09/2018
GOLETA, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, is scheduled to [...]
Auxly Cannabis Group and Kaneh Bosm BioTechnology Inc. Announce Strategic Investment and Partnership and Name Change of KBB to ICC International Cannabis Corp.
17/09/2018
VANCOUVER, British Columbia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") and Kaneh Bosm BioTechnology Inc. (CSE: KBB)(FWB: 8K51)(OTC: KNHBF [...]
VIDEO: Aleafia’s 160,000 sq. ft. Greenhouse Retrofitting on Schedule
17/09/2018
Video Provides Inside Look at Aleafia’s two Fully Funded, Modern Production Facilities TORONTO, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company [...]
BioCryst Receives Additional $3.5 Million to Fund Clinical Trials of Galidesivir in Yellow Fever
17/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National [...]
Protalix BioTherapeutics to Present Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 1st Canadian Symposium on Lysosomal Diseases 2018
17/09/2018
~Oral Presentation to Include preliminary Kidney Function Data from First 16 Patients Enrolled~ CARMIEL, Israel, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a [...]
Natus Appoints Drew Davies Executive Vice-President and CFO
17/09/2018
PLEASANTON, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:BABY) today announced the appointment of Drew Davies as Executive Vice-President and Chief Financial Officer, effective October 1 [...]
The Gokhale Method Announces Wireless Charging-Enabled Gokhale SpineTracker™
17/09/2018
Wearable device features new wireless charging capabilities to improve flexibility and efficiency in education and trainings PALO ALTO, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- The Gokhale Method , a health and [...]
G1 Therapeutics to Report Myelopreservation Data from Randomized Phase 2 Trial of Trilaciclib/Chemotherapy/Tecentriq® in Small Cell Lung Cancer in Fourth Quarter 2018
17/09/2018
Management to host webcast and conference call today at 8:30 a.m. ET RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today [...]
Progenics Announces Addition of AZEDRA® (iobenguane I 131) to National Comprehensive Cancer Network Guidelines for Pheochromocytoma and Paraganglioma
17/09/2018
NEW YORK, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Tasly Pharmaceutical Group Receives All Necessary Approvals for Transaction With Mesoblast
17/09/2018
NEW YORK and MELBOURNE, Australia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; Nasdaq: MESO) today announced that Tasly Pharmaceutical Group has successfully obtained all necessary approvals, [...]
PotNetwork Holdings' Diamond CBDShowcases Growing Product Line in Miami at 2018 World Vapor Expo
17/09/2018
FT. LAUDERDALE, Fla., Sept. 17, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE-- PotNetwork Holdings, Inc. (OTC Pink: POTN ) is pleased to announce that its wholly owned subsidiary, Diamond CBD , Inc., drew a substantial [...]
Genetic Technologies Invited to Establish a Market Presence in Hainan, China
17/09/2018
MELBOURNE, Australia, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Hainan Resort Software Community(“ HRSC ”) has on behalf of Hainan Ecological Smart City Group (“ HESCG ”) formally extended an invitation to Genetic Technologies [...]
Creation of novel medicines and better patient care for the future in an ecosystem
17/09/2018
ORION CORPORATION PRESS RELEASE 17 SEPTEMBER 2018 Creation of novel medicines and better patient care for the future in an ecosystem Orion Corporation has together with selected university research groups and other [...]
OV - Updated LiPlaCis data positions LiPlaCis and its DRP for an FDA Breakthrough Therapy designation application for breast cancer
17/09/2018
Hoersholm, Denmark, September 17, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) ("OV" or "the Company") announce the fourth update from the ongoing LiPlaCis ® Phase 2 study. In the ongoing study, the [...]
Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board
17/09/2018
Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading [...]
Shire plc: Rule 2.9 Announcement
17/09/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 17 September 2018 [...]
Launch of Alcon Experience Academy Reinforces Commitment to Training and Education for Eye Care Professionals
17/09/2018
Alcon Experience Academy serves as umbrella for industry-leading training and educational resources for all eye care professionals New website houses a robust library of more than 500 videos, including webcasts and [...]
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018
17/09/2018
Curetis To Attend Key Investor and Scientific Conferences In The Fourth Quarter 2018 Amsterdam, the Netherlands, San Diego, CA, USA and Holzgerlingen, Germany , September 17, 2018 , 01:00 a.m. EST -- Curetis N.V. (the [...]
argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia
17/09/2018
Favorable safety and tolerability consistent with efgartigimod clinical trials to date Clinically meaningful platelet count improvements showed clear separation from placebo at increasing response thresholds Plan to [...]

Pages